 Connection
Nicholas Cost to Chemotherapy, Adjuvant
This is a "connection" page, showing publications Nicholas Cost has written about Chemotherapy, Adjuvant.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.232 |
|
|
|
-
Cost NG, Krabbe LM, Bagrodia A, Margulis V. The use of preoperative targeted molecular therapy to allow nephron sparing for T1b tumors. Curr Opin Urol. 2013 Sep; 23(5):411-7.
Score: 0.101
-
Cost NG, Delacroix SE, Sleeper JP, Smith PJ, Youssef RF, Chapin BF, Karam JA, Culp S, Abel EJ, Brugarolas J, Raj GV, Sagalowsky AI, Wood CG, Margulis V. The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus. Eur Urol. 2011 Jun; 59(6):912-8.
Score: 0.085
-
Walther A, Cost NG, Garrison AP, Geller JI, Alam S, Tiao GM. Renal rhabdomyosarcoma in a pancake kidney. Urology. 2013 Aug; 82(2):458-60.
Score: 0.025
-
Margulis V, Master VA, Cost NG, Leibovich BC, Joniau S, Kuczyk M, Mulders PF, Kirkali Z, Wirth MP, Hirao Y, Rawal S, Chong TW, Wood CG. International consultation on urologic diseases and the European Association of Urology international consultation on locally advanced renal cell carcinoma. Eur Urol. 2011 Oct; 60(4):673-83.
Score: 0.022
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|